返回 Agenda
Session 2: Insights from Industry on the Implementation of FDA Policies and Regulations
Session Chair(s)
Nicol George, PharmD, RPh
Executive Vice President, Promotional Review & Labeling Services
ProPharma Group, United States
This session will provide further FDA insight into policies and regulations and allow for an interactive discussion between FDA and industry on best practices and tools for implementation.
Building on the discussion from Session 1, this session will further explore key FDA policies and regulations that have shaped the industry over the past year. With a focus on best practices and implementation strategies, the session will provide an interactive forum for industry professionals to discuss challenges, share insights, and explore practical approaches to compliance.
Learning Objective : - Interpret FDA policies and regulations to help develop compliant prescription drug advertising and promotion
- Discuss key takeaways and learnings regarding the future of social media, the CCN Final Rule and compliance activities
-
Identify common pitfalls with prescription drug promotion and discuss tools and strategies to address them
Speaker(s)
Insights from the Industry on Implementation – Policies and Regulations
Lisa Hubbard, RPh, RAC
Opus Regulatory, Inc., United States
Principal Consultant, Regulatory Advertising and Promotion
Insights from the Industry on Implementation – Policies and Regulations
Josephine Secnik, MBA, MS
Eli Lilly and Company, United States
Executive Director – Product Communications Regulatory Affairs